These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 9923557

  • 1. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
    Alexopoulos K, Kouroussis C, Androulakis N, Papadakis E, Vaslamatzis M, Kakolyris S, Samelis G, Patila E, Vossos A, Samantas E, Georgoulias V.
    Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
    Kourousis C, Androulakis N, Kakolyris S, Souglakos J, Maltezakis G, Metaxaris G, Chalkiadakis G, Samonis G, Vlachonikolis J, Georgoulias V.
    Cancer; 1998 Nov 15; 83(10):2083-90. PubMed ID: 9827712
    [Abstract] [Full Text] [Related]

  • 4. Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial.
    Georgoulias V, Ardavanis A, Agelidou A, Agelidou M, Chandrinos V, Tsaroucha E, Toumbis M, Kouroussis C, Syrigos K, Polyzos A, Samaras N, Papakotoulas P, Christofilakis C, Ziras N, Alegakis A.
    J Clin Oncol; 2004 Jul 01; 22(13):2602-9. PubMed ID: 15226327
    [Abstract] [Full Text] [Related]

  • 5. First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
    Georgoulias V, Androulakis N, Dimopoulos AM, Kourousis C, Kakolyris S, Papadakis E, Apostolopoulou F, Papadimitriou C, Vossos A, Agelidou M, Heras P, Tzannes S, Vlachonicolis J, Mavromanolakis E, Hatzidaki D.
    Ann Oncol; 1998 Mar 01; 9(3):331-4. PubMed ID: 9602269
    [Abstract] [Full Text] [Related]

  • 6. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V, Kourousis C, Androulakis N, Kakolyris S, Papadakis E, Bouros D, Apostolopoulou F, Georgopoulou T, Agelidou M, Souglakos J, Halkiadakis G, Hatzidaki D.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [Abstract] [Full Text] [Related]

  • 7. Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
    Kakolyris S, Papadakis E, Tsiafaki X, Kalofonos C, Rapti A, Toubis M, Bania E, Kouroussis C, Chainis K, Androulakis N, Agelaki S, Sarra E, Vardakis N, Georgoulias V, Greek Cooperative Group for Lung Cancer.
    Lung Cancer; 2001 May 01; 32(2):179-87. PubMed ID: 11325489
    [Abstract] [Full Text] [Related]

  • 8. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ, Leighton JC, Comis RL, O'Dwyer PJ, McAleer CA, Bonjo CA, Engstrom PF, Litwin S, Johnson S, Ozols RF.
    Semin Oncol; 1995 Aug 01; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [Abstract] [Full Text] [Related]

  • 9. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [Abstract] [Full Text] [Related]

  • 10. A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
    Kouroussis C, Agelaki S, Mavroudis D, Kakolyris S, Androulakis N, Kalbakis K, Souglakos J, Mallas K, Bozionelou V, Pallis A, Adamtziki H, Georgoulias V.
    Anticancer Res; 2003 Dec 01; 23(1B):785-91. PubMed ID: 12680184
    [Abstract] [Full Text] [Related]

  • 11. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ, Meyers FJ, Houston J, Lauder I.
    Semin Oncol; 1997 Oct 01; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of paclitaxel poliglumex as first-line chemotherapy in patients at high risk with advanced-stage non-small-cell lung cancer: results of a phase II study.
    Richards DA, Richards P, Bodkin D, Neubauer MA, Oldham F.
    Clin Lung Cancer; 2005 Nov 01; 7(3):215-20. PubMed ID: 16354318
    [Abstract] [Full Text] [Related]

  • 13. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
    Cascinu S, Graziano F, Barni S, Labianca R, Comella G, Casaretti R, Frontini L, Catalano V, Baldelli AM, Catalano G.
    Br J Cancer; 2001 Feb 01; 84(4):470-4. PubMed ID: 11207039
    [Abstract] [Full Text] [Related]

  • 14. Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.
    Fossella FV, Lee JS, Berille J, Hong WK.
    Semin Oncol; 1995 Apr 01; 22(2 Suppl 4):22-9. PubMed ID: 7740327
    [Abstract] [Full Text] [Related]

  • 15. Emerging role of docetaxel (Taxotere) in advanced non-small cell lung cancer.
    Gandara DR, Edelman MJ, Lau D.
    Semin Oncol; 1999 Jun 01; 26(3 Suppl 10):3-7. PubMed ID: 10437743
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
    Langer CJ, Leighton J, McAleer C, Comis R, O'Dwyer P, Ozols R.
    Semin Oncol; 1995 Jun 01; 22(3 Suppl 6):64-9. PubMed ID: 7541156
    [Abstract] [Full Text] [Related]

  • 17. Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer.
    Le Chevalier T, Bérille J, Zalcberg JR, Millward MJ, Monnier A, Douillard JY, McKeage MJ, James R, Soulas F, Loret C, Bougon N, Bizzari JP.
    Semin Oncol; 1999 Jun 01; 26(3 Suppl 11):13-8. PubMed ID: 10458205
    [Abstract] [Full Text] [Related]

  • 18. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V.
    Oncology (Williston Park); 1997 Aug 01; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [Abstract] [Full Text] [Related]

  • 19. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
    Fischer JR, Manegold C, Bülzebruck H, Vogt-Moykopf I, Drings P.
    Semin Oncol; 1994 Jun 01; 21(3 Suppl 4):20-7. PubMed ID: 7516094
    [Abstract] [Full Text] [Related]

  • 20. A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.
    Lee JS, Komaki R, Morice RC, Ro JY, Kalapurakal SK, Schea R, Murphy WK, Shin DM, Fox NT, Walsh GL, Hittelman WN, Hong WK.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):121-9. PubMed ID: 10210551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.